“A condition or circumstance that puts a company in a favourable or superior business position”.
A business is said to be on a competitive advantage when it could offer the same product to consumers which the competitor offers but at substantially lower prices, thus benefiting the consumer on cost benefits and cutting down the competition by lowering the margins.
The arbitrage of margins between two companies depends on the process innovation and reduction in manufacturing cost.
Clean sciences technology ltd and Camlin fine sciences ltd are two prime examples for the above case study.
Both the companies manufacture performance chemicals and food antioxidant products, however one has a competitive advantage over the other as both of the companies follow different methods of manufacturing.
If we understand the value chain, CSTL manufactures the antioxidant products from anisole route and CFS uses the hydroquinone route. With the help of anisole route, CSTL is able to bag the operating margins above 50% but CFS is struggling to sustain the 15% margins level.
So why not CFS start using the anisole route and stop the hydroquinone route?
Conventionally, anisole was synthesised by reacting sodium hydroxide with phenols, however CSTL has developed the proprietary technology to manufacture anisole from vapour phase technology.
The phenol undergoes vaporisation in the presence of a catalyst which is only known by CSTL resulting in their key product anisole. It occurs in a one step reaction thus the cost of production is low.
The anisole is further integrated to manufacture value added products i.e MEHQ and BHA.
Camlin fine sciences lacks the knowledge of the use of catalyst and vapour phase technology and still follows the conventional route to manufacture MEHQ from hydroquinone.
One major drawback while manufacturing hydroquinone from phenols is that a by-product is created in larger quantities i.e catechol. Catechol has limited applications compared to MEHQ and BHA, thus the demand is low and keeps on adding in the inventory.
If the demand for hydroquinone increases, the production also increases followed by the generation of catechol.
CSTL is further introducing TBHQ and PBQ. TBHQ is a product in the antioxidant basket and demanded by the existing customer
so that all the antioxidants are procured from a single supplier. This will result in increasing wallet share with existing customers and taking the market share from existing competitors. However, both the products will be manufactured from hydroquinone route and not through
anisole route but using catalytic oxidation technology. CSTL is under no plans to backward integrate the hydroquinone value chain because of the extra by-product alongside i.e catechol.
Directly procuring hydroquinone from the open market is economically beneficial as it is a commodity product.
PBQ is imported in India and the manufacturing of the product will result in import substitution. CSTL is developing a PTZ product which is a very important antioxidant but they aren't yet successful in developing the technology yet.
Technocrat promoters and expertise to handle catalytic chemistry gives the CSTL competitive advantage over CFS. The picture for clean science looks positive, however, one should not forget Charlie Munger's ‘Inversion” mental model.
The technology which is used by CSTL is not patented which makes them highly prone to threat of infringement of technology. Also, in recent updates from camlin fine science management, it is mentioned that CFS is working on anisole route to manufacture
their products. CFS has also shifted the manufacturing units from overseas territory to India which will benefit on cost of production.
If CFS successfully implements the anisole technology, similar margins of CSTL will be expected by CFS. The risk to reward ratio for CSTL stands very high and so are the valuations.
With rise in environmental concerns and search for reducing the dependency on natural resources, the energy sector is revolutionising from non-renewable
energy to renewable energy. Increased spending on R&D for renewable energy has evolved the generation of electricity from mechanical generation to chemical generated electricity. In mechanical transformation, the electricity was generated by
rotating the turbine and converting the electromagnetic energy, for example a hydroelectric plant. In chemical conversion, certain chemicals are used in a mixture to derive electric energy from the reaction, for example lead acid batteries.
Can #CDSL & #IEX reinvest the earnings in the business ? These businesses won't need much cash to grow.
#CDSL have market linked revenue so business will have some cyclicality. Opportunity size is huge
#IEX 1. Revenues are not linked to market. 2. Excellent business model with super high margins and ROCE and it don't need any capital to grow. 3. But govt regulation can be a double edged sword which keeps the competition away but also can kill you.
4. Big opportunity size after MBED #Saregama & #Tips 1. Unique business model. 2. No or very less cost for incremental revenues (For already acquired copyrights which don't have royalties) 3. No cyclicality in business (Like CDSL)
What resources I use to understand chemical industry ? 🧪🧪
Like and retweet for max reach !
Understanding chemical industry can be technical and may take some time to sink in.
I use following resources to understand different businesses
1. Annual report of last 10 years
2. All the available concalls - This is must to understand product details. Competitive structure in industry, Capex plan,Complexity of manufacturing, Import substitution, Execution Capabilities.
If I am researching aarti industries
then
Along with aarti industries concalls I will read competitiors concalls also ( Seya Industries - almost bankrupt, Bodal chemicals - Entering into benzene chain )
This gives good understanding of products and value chains and what capex competitiors are planning.
The crude oil prices have made new highs and are sustaining above 100$/ barrel levels. Due to global tensions and supply disruption challenges, the natural resource is expected to continue the uptrend.
The uptrend in crude oil prices will have a direct impact on the petrochemical derivatives and downstream products of crude oil, thus impacting the margins in the chemical sector.
The aromatic compounds such as benzene, toluene, xylene etc are direct petrochemical derivatives, thus higher dependency of the chemical companies on the petrochemical value chain will result in margin erosion.
India is the global leader in providing cost-effective medications to the world. It is the third largest exporter of pharmaceuticals by volume, supplying about 20% of the global volume and about 50% of the global demand for vaccines. Indian companies primarily
manufacture generic medications to cater to domestic demand and for export. While a lot of companies are engaged in the business of manufacturing commodity generics for export, the domestic market comprises mainly branded generics.
While researching on the chemical company there are many factors taken into consideration, but a few of them play a crucial role in the future developments of the company.
The growth of any business is dependent on the income generation and profit expansion. This could be met through increasing the capacity or operating in low volume high value products.
Similarly in the chemical industry, scaling up plays a crucial role in determining the growth of revenues, however working in niche chemistry with high expertise results in margin expansion.